2014
DOI: 10.1016/j.jtbi.2014.02.017
|View full text |Cite
|
Sign up to set email alerts
|

Molecular modeling and molecular dynamics simulations of GPI 14 in Leishmania major: Insight into the catalytic site for active site directed drug design

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
8
0
1

Year Published

2015
2015
2023
2023

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 19 publications
(11 citation statements)
references
References 34 publications
0
8
0
1
Order By: Relevance
“…GPI-14 is a rational target for leishmaniasis chemotherapy since it is a key enzyme in the biosynthesis of LPG and GIPLs, which are important molecules in the parasite’s interaction with vertebrate and invertebrate hosts and has a structural variation in the side chain and lipid moiety compared to humans [14]. Ruhela et al [29] described the synthesis and evaluation of new iminosugars as inhibitors of GPI-14 using microsomal membranes from L. donovani .…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…GPI-14 is a rational target for leishmaniasis chemotherapy since it is a key enzyme in the biosynthesis of LPG and GIPLs, which are important molecules in the parasite’s interaction with vertebrate and invertebrate hosts and has a structural variation in the side chain and lipid moiety compared to humans [14]. Ruhela et al [29] described the synthesis and evaluation of new iminosugars as inhibitors of GPI-14 using microsomal membranes from L. donovani .…”
Section: Discussionmentioning
confidence: 99%
“…GPI-14 is functionally different from that of the mammalian pathway. Structural variations in the side chain and lipid moiety between Leishmania and humans make GPI-14 a rational drug target [14]. In addition, this enzyme can be a good target for antiparasitic chemotherapy due to its role in the biosynthesis of LPG and GIPLs, which are important molecules involved in the parasite’s infection cycle.…”
Section: Introductionmentioning
confidence: 99%
“…In addition, the inability of CaGpi14‐deficient cells to undergo yeast to hyphal transitions should drastically limit the invasiveness and virulence of the organism (Sudbery, ). Some attempts have been made in recent times to model the Gpi14 enzyme from Leishmania major as a drug target and to identify probable candidate molecules that would specifically inhibit the protozoan enzyme (Shinde et al ., ). CaGpi14 could provide a similar target in C .…”
Section: Resultsmentioning
confidence: 97%
“…Among the Leishmania spp. inferred orthologous groups without hits against the human proteome (Table 4 ) are proteins already described in the literature as possible drug targets, briefly: trypanothione [ 53 ] (K01833.cdhit) – which relates to defense against oxidative stress [ 54 ]; and alpha-1,3-mannosyltransferase [ 55 , 56 ] (K13690.cdhit) – enzyme essential to add mannose on the glycosylphosphatidyl, relates to the growing resistance to miltefosine. However, there are also other proteins, not yet described as drug targets, which should be further studied, briefly: the energy-converting hydrogenase B subunit I [ 55 ] (K14118.cdhit), found in the Archaea organism Methanothermobacter thermautotrophicus , which belongs to a domain related to MnhB subunit of Na+/H+ antiporter and is predicted as an integral membrane protein [ 57 , 58 ]; and galactofuranosyltransferase [ 59 ] (K13672.cdhit), related to the LPG1 gene, which acts as a major ligand for macrophage adhesion [ 60 , 61 ].…”
Section: Discussionmentioning
confidence: 99%